Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medinet CoTSE:2370 45 Days Inventory is 50.85 as of Mar. 2026, which is 65% above its 10-year median of 30.76. GuruFocus rates TSE:2370 with a GF Score™ of 45/100 and a GF Value™ of 円41.73 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 638 Biotechnology companies, Medinet Co ranks better than 89.66% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Medinet Co's Average Total Inventories for the
three
months ended in Mar. 2026 was 円77.6 Mil. Medinet Co's Cost of Goods Sold for the
three
months ended in Mar. 2026 was 円139.2 Mil.
Hence, Medinet Co's Days Inventory for the
three
months ended in Mar. 2026 was 50.85.
The historical rank and industry rank for Medinet Co's Days Inventory or its related term are showing as below:
TSE:2370'
s Days Inventory Range Over the Past 10 Years
Min: 20.76 Med: 30.76 Max: 39.08
Current: 37.1
During the past 13 years, Medinet Co's highest Days Inventory was 39.08. The lowest was 20.76. And the median was 30.76.
TSE:2370's Days Inventory is ranked better than 89.66% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs TSE:2370: 37.10
Medinet Co's Days Inventory
increased
from Mar. 2025 (0.00) to Mar. 2026 (50.85).
It might indicate that Medinet Co's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Medinet Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.79.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medinet Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.33.
Medinet Co (TSE:2370) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Medinet Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Medinet Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Medinet Co Days Inventory Related Terms
Medinet Co Days Inventory Historical Data
* Premium members only.
The historical data trend for Medinet Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2370 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Medinet Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinet Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Medinet Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Medinet Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medinet Co (TSE:2370) has a Days Inventory of 50.85 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medinet Co and its competitors. This is 65% above median its historical median of 30.76. Over the past decade, Medinet Co's Days Inventory has ranged from 20.76 to 39.08. According to the industry distribution chart, Medinet Co ranks #66 out of 638 companies in the Biotechnology industry, placing it in the top 10.3%.
Is Medinet Co's Days Inventory too high?
Medinet Co's current Days Inventory of 50.85 is 65% above median its 10-year median of 30.76. Over the past 10 years, this metric has ranged from a low of 20.76 to a high of 39.08. The Biotechnology industry median Days Inventory is 183.20. Medinet Co's value of 50.85 is 72.2% below this industry median. Based on the distribution chart, Medinet Co ranks #66 out of 638 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Medinet Co has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medinet Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Medinet Co ranks #66 out of 638 companies for Days Inventory. This places Medinet Co in the top 10% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.20. Medinet Co's value of 50.85 is 72.2% below this benchmark. Historically, Medinet Co's own Days Inventory has ranged from 20.76 to 39.08 over the past decade. While the company's 10-year median is 30.76 vs. the industry median of 183.20, Medinet Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medinet Co's current Days Inventory of 50.85 is 72.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Medinet Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinet Co's current Days Inventory is 50.85, which is 65% above median its own 10-year median of 30.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinet Co stock overvalued right now?
Based on GuruFocus' analysis, Medinet Co (TSE:2370) is currently considered Possible Value Trap. The stock's GF Value™ is 円41.73, compared to a current price of 円25.00 — trading 40.1% below its estimated fair value. The current Days Inventory is 50.85, which is 65% above median its 10-year median of 30.76 and 72.2% below the Biotechnology industry median of 183.20. Medinet Co's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Medinet Co (TSE:2370), the current Days Inventory is 50.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medinet Co (TSE:2370) Overvalued in 2026?
Based on GuruFocus' analysis, Medinet Co stock appears to be undervalued.
The current stock price of 円25.00 is trading 40.1% below its estimated GF Value™ of 円41.73.
GuruFocus considers Medinet Co to be Possible Value Trap.
Key valuation signals for TSE:2370:
Days Inventory: 50.85 (65% above median its 10-year median of 30.76)
GF Value™: 円41.73 vs. price of 円25.00 (40.1% below fair value)
Industry Position: 72.2% below the Biotechnology median (#66 of 638)
No single metric tells the full story. See the TSE:2370 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.
45GF Score
Get the complete analysis for TSE:2370
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2370 has been successfully added to your 
